donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > VRAX Virax Biolabs > Detailed Quotes

VRAX Virax Biolabs

6.680
-0.360-5.11%
Trading Session 08/12 13:26 ET
High
7.350
Open
6.900
Turnover
2.96M
Low
6.530
Pre Close
7.040
Volume
429.46K
Market Cap
75.98M
P/E(TTM)
Loss
52wk High
29.000
Shares
11.37M
P/E(Static)
Loss
52wk Low
5.400
Float Cap
9.02M
Bid/Ask %
89.47%
Historical High
29.000
Shs Float
1.35M
Volume Ratio
0.72
Historical Low
5.400
Dividend TTM
--
Div Yield TTM
--
P/B
-95.43
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
31.81%
Amplitude
11.65%
Avg Price
6.895
Lot Size
1
Float Cap
9.02M
Bid/Ask %
89.47%
Historical High
29.000
Shs Float
1.35M
Volume Ratio
0.72
Historical Low
5.400
Dividend TTM
--
P/B
-95.43
Dividend LFY
--
Turnover Ratio
31.81%
Amplitude
11.65%
Avg Price
6.895
Lot Size
1
Price Forecast

No Data

News

Comment

Company Overview More
Virax Biolabs Group Limited, a biotechnology company, sells, distributes, and markets diagnostics test kits, and med-tech and PPE products for the prevention, detection, diagnosis, and risk management of viral diseases in the field of immunology. The company offers rapid antibody IgC/IgM tests, antigen tests, polymerase chain reaction rapid tests, and neutralizing antibody tests under the ViraxClear brand name; and med-tech and PPE products, such as employee protection equipment products under the ViraxCare brand name. It also distributes nebulizing machines and smart wearable devices that alert employees to help them follow social distance guidelines. In addition, the company operates an online platform that sells ViraxClear and ViraxCare products. It serves clinics, pharmacies, laboratories, hospitals, and other groups, as well as corporations, employees, and individual consumers. The company operates in Europe, South America, the Asia Pacific, Sub-Saharan Africa, and internationally. The company was formerly known as Virax Biolabs (Cayman) Limited and changed its name to Virax Biolabs Group Limited in September 2021. The company was incorporated in 2021 and is based in London, the United Kingdom.
CEO: Foster, James
Market: NASDAQ
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...